RM LAW, P.C. is investigating potential claims against the board of directors of KMG Chemicals, Inc. (“KMG” or the “Company”) (NYSE: KMG) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell the Company to Cabot Microelectronics Corporation (“Cabot”) in a transaction valued at approximately $1.6 billion.
If you own shares of KMG and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here. You may also email Mr. Maniskas at firstname.lastname@example.org.
Under the terms of the agreement, shareholders of KMG will receive a combination of $55.65 in cash and 0.2000 shares of Cabot common stock per share of KMG common stock.
Our investigation concerns possible breaches of fiduciary duty and other violations of state law by the board of directors of KMG for not acting in the Company’s shareholders’ best interests in connection with the sale process.